Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol

Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol

Abstract Background New generation hormone-therapies (NGHT) targeting the androgen signalling pathway are nowadays proposed to elderly patients with metastatic castration-resistant prostate cancer (CRPCa). The impact of these treatments on cognitive function has never been evaluated whereas cognitiv...

Full description

Bibliographic Details
Main Authors: Marie Lange, Heidi Laviec, Hélène Castel, Natacha Heutte, Alexandra Leconte, Isabelle Léger, Bénédicte Giffard, Aurélie Capel, Martine Dubois, Bénédicte Clarisse, Elodie Coquan, Frédéric Di Fiore, Sophie Gouérant, Philippe Bartélémy, Laure Pierard, Karim Fizazi, Florence Joly
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Cancer
Subjects:
Cognitive impairments
Ageing
Prostate cancer
Hormone therapy
Adherence
Quality of life
Online Access:http://link.springer.com/article/10.1186/s12885-017-3534-8

Internet

http://link.springer.com/article/10.1186/s12885-017-3534-8

Similar Items